, Tracking Stock Market Picks
Enter Symbol:
Oxigene, Inc. (OXGN) [hlAlert]

down 99.38 %

Oxigene, Inc. (OXGN) rated Buy by Merriman Curhan Ford

Posted on: Thursday,  Feb 12, 2009  8:25 AM ET by Merriman Curhan Ford

Merriman Curhan Ford rated Buy Oxigene, Inc. (NASDAQ: OXGN) on 02/12/2009, when the stock price was $187.20. Since
then, Oxigene, Inc. has lost 99.38% as of 09/10/2015's recent price of $1.16.
If you would have followed this Merriman Curhan Ford's recommendation on OXGN, you would have lost 99.38% of your investment in 2401 days.

OXiGENE, Inc. (OXiGENE) is a clinical-stage, biopharmaceutical company developing therapeutics to treat cancer and eye diseases. The Company?s primary focus is the development and commercialization of product candidates referred to as vascular disrupting agents (VDAs) that selectively disable and destroy abnormal blood vessels that provide solid tumors a means of growth and survival and also are associated with visual impairment in a number of ophthalmological diseases and conditions. Approximately 375 subjects have been treated with ZYBRESTAT in human clinical trials.

We occupy a unique niche among our investment banking peers: we offer our clients both traditional sell-side equity research and primary market research, and we focus on high-potential sectors such as CleanTech, Consumer/Internet/Media, Health Care and Tech/Telecom. Our institutional and corporate clients get the best of both worlds: expertise from our analysts and access to experts through our Panel Intelligence platform.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/12/2009 8:25 AM Buy
as of 12/31/2009
1 Week down  -83.47 %
1 Month down  -82.75 %
3 Months down  -85.91 %
1 YTD down  -74.35 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy